ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Total assets

Nxera Pharma Co., Ltd. (4565)

Market cap
¥91.7B
P/E ratio
Nexera Pharma discovers, develops and commercializes innovative specialty pharmaceuticals to improve patient quality of life in Japan and worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Dec 31, 2025134,787-11.03%
Dec 31, 2024151,498-3.63%
Dec 31, 2023157,198+58.12%
Dec 31, 202299,417+2.51%
Dec 31, 202196,985+26.84%
Dec 31, 202076,465+34.91%
Dec 31, 201956,680-3.91%
Dec 31, 201858,987-15.32%
Mar 31, 201869,658+44.67%
Mar 31, 201748,151-1.11%
Mar 31, 201648,690+1.01%
Mar 31, 201548,203

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat